PRPO

Precipio, Inc. · NASDAQ

Sector Health Services
Industry Medical/Nursing Services
Website recipiodx.com
Employees(FY) 53
ISIN US74019L6020

Performance

+0.85%

-5.4%

-9.15%

+3.47%

-8.31%

YTD

-10.62%

Profile

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

Advanced Technical Analysis

Technical Analysis of PRPO 2024-12-02

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 13 indicating strong downward pressure, while the Oscillators Score of 53 suggests a neutral stance. Overall, the Technical Score of 33 reinforces the bearish outlook, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PRPO

Stock Rank

Recent News & Updates

2024-11-19 19:00
Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ...(Yahoo Finance)
2024-11-06 04:00
Precipio Announces Q3-2024 Shareholder Update Call(Globenewswire)
2024-10-07 22:00
Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping(Globenewswire)
2024-09-06 04:00
Precipio Announces Employee Stock Option Plan Repricing(Globenewswire)
2024-08-15 05:00
Precipio Announces Q2-2024 Shareholder Update Call(Globenewswire)
2024-07-24 21:00
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven(Globenewswire)
2024-07-16 21:00
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024(Globenewswire)
2024-06-13 04:00
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders(Globenewswire)
2024-06-12 04:00
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting(Globenewswire)
2024-06-11 21:00
Precipio Provides Status Update on Current Business Matters(Globenewswire)
2024-05-14 20:52
PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-06 05:00
Precipio Secures a short-term $500K Credit Facility(Globenewswire)
2024-03-31 22:53
PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023(Investorplace)
2024-03-25 05:00
Precipio Announces Year end 2023 Shareholder Update Call(Globenewswire)
2024-02-12 21:00
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY(Globenewswire)
2024-02-05 21:00
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer(Globenewswire)
2024-01-22 21:00
Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter(Globenewswire)
2024-01-16 21:30
Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan(Globenewswire)
2024-01-01 20:00
Precipio Announces Christina Valauri joins the Board of Directors(Globenewswire)
2023-12-14 03:30
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024(Globenewswire)
2023-11-16 04:00
Precipio Announces Q3-2023 Shareholder Update Call(Yahoo Finance)
2023-10-17 21:00
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022(Globenewswire)
2023-10-02 22:00
Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023(Globenewswire)
2023-09-27 21:00
Precipio Continues to Sign New HemeScreen Customers(Globenewswire)
2023-09-24 23:00
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven(Yahoo Finance)
2023-09-20 21:00
Precipio Takes Final Step Towards Regaining Nasdaq Compliance(Yahoo Finance)
2023-09-12 21:30
Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan(Yahoo Finance)
2023-08-31 03:26
11 ChatGPT Penny Stock Picks(Yahoo Finance)
2023-08-18 18:01
Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript(Yahoo Finance)
2023-08-12 22:16
Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.